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Abstract 
 
Activated B lymphocytes in peripheral lymphoid organs undergo class switch recombination 
and somatic hypermutation of antibody genes to produce antibodies with higher antigen-binding 
affinity. These processes are initiated by the DNA mutator enzyme activation–induced cytidine 
deaminase (AID) which mutates cytidine to uridine at Immunoglobulin loci. AID activity also 
results in mutations across the genome which in turn causes and exacerbates cancers. In vitro, 
AID mutates single stranded but not double-stranded oligonucleotide DNA substrates whereas 
in vivo, it acts preferentially on loci that are robustly transcribed or contain unusual 
transcriptional features. Taken together, AID is thought to target single stranded DNA liberated 
during transcription. In addition, AID has been shown to interact with factors associated with 
transcription, including the RNA exosome and spliceosome components, and with non-coding 
RNA itself. Here, we examined the behavior of purified AID on DNA/RNA hybrid substrates 
designed to simulate structures found at Immunoglobulin loci. We found that when composed 
of Immunoglobulin switch sequences, DNA/RNA hybrids significantly boost the catalytic 
activity of AID. We also identified numerous AID mutants which are catalytically inactive on 
DNA, whose activity is restored by proximity to RNA. Given the prevalence of RNA:DNA 
hybrids at Immunoglobulin switch sequences, our finding that RNA directly enhances the 
catalytic activity of AID on DNA suggest a novel role for RNA in regulating AID activity.
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Introduction 
 
 
1.1 The immune system 
 
The immune system across species varies from basic and rudimentary in bacteria to 
complex subsystems in multi cellular organisms. In humans, for example, the immune system 
consists of two main subsystems: innate and adaptive immunity. Such a defence system ensures 
a thorough protection for the host in parallel with their surrounding environment and constantly 
evolving pathogens (Beck et al., 1996; Fliesher, 1997, Warrington et al., 2011). 
During an innate immune response which is considered the first line of antigen and toxin 
resistance in the organism, an immediate protection against foreign invaders, be it through 
physical barriers such as the skin, or more specific chemical barriers that involve secretion of 
mucus, saliva, tears and several gastrointestinal tract enzymes is provided. This subsystem also 
encompasses specific types of cells that are responsible for capturing pathogens and destroying 
them with the help of the complement system. These cells present pattern recognition receptors 
(PPRs) that recognize pathogen-associated molecular patterns (PAMPs) thereby differentiating 
pathogens from host molecules (Akira et al., 2006). 
The adaptive immune response on the other hand provides more specific and long-lasting 
protection to the organism by creating immunological memory from an initial response. The 
cells involved in this subsystem are known as lymphocytes which are highly specialized and 
specific to particular pathogens. These lymphocytes consist of B-cells which mature in the bone 
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marrow and T-cells that mature in the thymus. T-cells contribute to cell mediated immune 
responses through its various subsets. T helper (TH) cells, for example, regulate the active 
immune response while cytotoxic (TC) cells wipe out virus-infected cells and tumor cells. B- 
cells are responsible for antibody responses and include antibody secreting plasma cells and 
memory cells that allow protection from reoccurring foreign pathogens. B-cells specifically, 
play an important role in the adaptive immune response in that they interact with a wide range 
of antigens that activates them to further specialize under affinity maturation. 
 
1.2 Antibodies in the context of the immune system 
 
To achieve this great influence on host protection, naïve (inactivated) B-cells are covered 
with low affinity antibodies that are also called surface-expressed receptors (BCRs) or 
immunoglobulins (Ig). Antibodies are “Y” shaped proteins made up of two light and heavy 
polypeptide chains that are connected by disulphide bonds (Fig. 1). The polypeptide chains are 
further divided in to variable (V) regions and constant (C) regions. The V regions of the light 
chains and the highly variable loops of the heavy chain located at the “arms” of the “Y” shaped 
antibody are responsible for identifying and binding to antigens. The C region on the other hand 
serves as an anchor in the B-cell membrane as well as a basis for the isotope and effector functions 
of the antibody by binding to receptors on other immune cells (Barreto et al., 2005; Fleisher, 
1997). 
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(Adapted from abcam protocols) 
 
Figure 1. Antibody structure and isotypes 
 
Antibodies are made of 2 light chains and 2 heavy chains shaped in a loose “Y” form. Fab, which 
is located at the N-terminus or the arm of the molecule is an antigen-binding region that is highly 
variable and specific. Fc on the other hand is located at the C-terminus and encompasses the tail 
of the antibody. It is responsible for interacting with cell surface receptors and complement 
proteins. Antibodies can be differentiated in to five isotypes (IgM, IgG, IgD, IgA and IgE) that 
vary in function. 
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1.3 Primary and Secondary antibody diversification 
 
Functional antibodies are first developed through the rearrangement of their genes in 
developing B lymphocytes in the bone marrow. This primary diversification process of 
antibodies is unique to lymphocytes and is also known as V(D)J recombination where V stands 
for “Variable”, D for “Diversity” and J for “Joining”. This process involves recombining signal 
DNA sequences (RSSs) that target RAG1 and RAG2 recombinases to the V, D and J genes to be 
cut and then joined back together by DNA repair enzymes (Gellert, 2002). The heavy chain 
genes are rearranged first and include the V, D and J segments that in turn account for the highly 
variable antigen-binding region of antibodies. This is followed by rearranging a paired 
“surrogate” (κ or λ) light chain through VJ recombination. Secondary antibody diversification 
processes are initiated in mature B-cells once they are activated by binding to an antigen, thus 
activating B-cells to migrate to secondary lymphoid organs (lymph nodes) to form germinal 
centers (GC) where they interact with T cells and become antibody-producing plasma cells that 
produce soluble antibodies (Gellert, 2002; Victora and Nussenzweig et al., 2012). Here, activated 
B-cells will undergo antibody affinity maturation, a process that will result in production of higher 
affinity and more effective antibodies thereby allowing a stronger immune response against the 
specific antigen. Affinity maturation requires class switch recombination (CSR) and somatic 
hypermutation (SHM), followed by cellular selection of B-cells. In CSR, the mature B-cells 
which produce IgM switch their antibody isotype to IgG, IgA and IgE isotypes. This occurs by 
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changing the antibody gene’s constant regions (CH) from Cμ to other CH genes, while retaining 
the same variable regions (Fig. 3) (Lanasa et al., 2011). This allows the antibody to preserve 
antigen specificity while assuming different effector functions from opsonisation, complement 
activation to antibody-dependent cell-mediated cytotoxicity (ADCC) and degranulation. On the 
other hand, SHM involves introducing numerous mutations in the form of single base 
substitutions in the genes that encode the variable region of antibodies. (Fig. 4). More 
specifically, it results in mutations in the hypervariable regions that correlate with the 
complementarity determining regions (CDRs) which encompass antigen recognition and 
binding on the antibody (Longerich, Basu, Alt, & Storb, 2006; Teng & Papavasiliou, 2007). 
SHM and CSR are initiated by a common DNA-specific modifying enzyme, activation 
induced cytidine deaminase (AID) (Longerich, Basu, Alt, & Storb, 2006). AID, a major player 
in antibody diversity, belongs to the Zn-dependent Apolipoprotein B m-RNA-editing, enzyme- 
catalytic polypeptide-like (APOBEC) superfamily of deaminases that mutate cytidine (C) to 
uridine (U) in RNA or deoxycytidine (dC) to deoxyuridine (dU) in DNA (Conticello, 2008) and 
is found and expressed in activated B-cells (Honjo, 2008). It is 24 kDa in size and in humans 
it’s 198 amino acids long (Fig. 2). In Somatic Hypermutation, AID acts by introducing point 
mutations in the antigen-binding coding sequences of the variable regions in immunoglobulin 
genes therefore creating higher affinity antibodies (Martin et al., 2002). However, in Class switch 
recombination, AID mutates G-C rich switch region sequences downstream of the constant 
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region genes thereby initiating double strand breaks that mediate recombination of the constant 
region genes (Okazaki et al., 2002). 
The essential role AID plays in these secondary antibody processes can be reflected in the 
absence of AID (Revy et al., 2000). It has been shown that while B-cell maturation or activation 
is not affected, AID deficient mice and humans lack CSR and SHM processes and thereby they 
suffer from Hyper IgM syndrome type immunodeficiency (HIGM) characterized by elevated 
IgM levels and diminished levels of switched immunoglobulin isotypes IgG, IgA and IgE 
causing a lack of high affinity antibodies and recurrent infections (Muramatsu et al., 2000). 
Hyper IgM syndrome consists of five subtypes that include defects in CD40LG (HIGM 1), AID 
(HIGM 2), CD40 (HIGM 3), UNG (HIGM 5) genes and class switch recombination 
downstream of the AID gene (HIGM 4). The most common defects are X-linked and autosomal 
recessive found in CD40L and AID genes and represent 70% and 25% cases of HIGM 
syndrome respectively (Cabral- Marques et al, 2014).To date, 47 AID mutations that include 
missense mutations, point mutations or frame shifts that cause premature stop codons, deletions 
and mutations that introduce improper splicing of the RNA have been reported (Table 1) (Imai 
et al., 2005, Durandy et al., 2006, Ouadani, et al., 2015, Caratão et al., 2013, Trotta et al, 2016). 
While all these mutations result in CSR deficiency, some also contribute to SHM impairment. 
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Figure 2. A ribbon model of a human wild-type AID 
 
A representative ribbon model of AID was predicted using I-TASSER and visualized using Pymol 
v1.30 based on the APOBEC family X-ray structures. Negatively charged residues shown in red 
(N-terminal) progress towards blue for positively charged residues (C-terminal). The Zn binding 
catalytic pocket is shown in purple and is characterized by Zn-coordinating (H56, C87, and C90) 
and catalytic (E58) residues. 
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Table 1. Updated list of AID mutations in HIGM 2 patients 
 
 
AID mutations library 
1 S3G\N168S 1 + α 6 25 L113P l 8 
2 K10R α 1 26 E122X α 4 
3 M6T l 1 27 R112C l 8 
4 R8-Y13del +F15X l 1 + α 1 28 R112H l 8 
5 L22X l 2 29 G133V l 9 
6 F11V α 1 30 C116X l 8 
7 R24W l 2 31 C147X α 5 
8 Y31X β 1 32 I136K β 5 
9 Y31H β 1 33 G125E α 4 
10 A25C l 2 34 M139T l 10 
11 S43P l 3 35 F151S α 5 
12 H56Y α 2 36 D143-L181delinsAfsX4 α 5 + α 6 
13 H56-E58del + L59F α 2 37 M139V l 10 
14 W68X l 5 38 S169X α 6 
15 W79-F81del β 3 39 R174S α 6 
16 E58K α 2 40 L181_P182ins31 α 6 + α 7 
17 W84X l 6 41 P182fsX208 α 7 
18 S85N l 6 42 R190X α 7 
19 L98R α 3 43 L181delinsCfsX26 α 6 
20 H56X α 2 44 H130P α 4 
21 C87S α 3 45 F15L α 1 
22 C87R α 3 46 W80R β 3 
23 S83P l 6 47 L106P β 4 
24 A111E l 8  
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(Adapted from Maizels, 2000) 
 
Figure 3. Class switch recombination entails DNA deletion 
 
Class switch recombination process takes place in the germinal centers of the lymph nodes and is 
initiated by AID which introduces double stranded breaks in the switch (S) regions resulting in 
the removal of the Cμ constant region and joining of a new constant region. This allows for 
different antibody isotypes with different effector functions to be expressed. 
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(Adapted from Bergmann, 2013) 
 
Figure 4. Schematic illustration of Somatic Hypermutation 
 
Another secondary antibody diversification process that occurs in the germinal center of the 
lymph nodes is Somatic Hypermutation. It targets antigen binding regions in the variable 
sequences of both heavy and light chains and increases their affinity to specific antigens by 
introducing point mutations in the V(D)J exon. Stars indicate mutations in the DNA 
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1.4 AID’s impact on cancer 
 
In contrast to its beneficial and necessary functions for antibody diversification, AID was 
also shown to mistarget and mutate genome-wide thereby creating DSBs on non-Ig genes which 
can lead to chromosomal translocations, causing and exacerbating cancers. In fact, AID was 
revealed to deaminate more than half of all transcribed non-Ig genes in germinal center B-cells 
(Liu et al., 2008). As another example, chromosomal translocations with several oncogenes in 
Ig switch region DNA in B lymphocytes that are induced by AID deamination, were also found to 
associate with extremely high percentages of lymphoid leukemias and lymphomas (Ramiro et 
al., 2004). A study has shown that during CSR, AID produces double stranded DNA breaks in 
immunoglobulin heavy-chain locus IgH which leads to c-myc/IgH reciprocal translocations 
and the subsequent formation of Burkitt’s lymphoma in humans and plasmacytomas in mice 
(Robbiani et al., 2008). Other proto-oncogenes that also underwent translocation/mutation due 
to AID activity include BCL2/IgH in Follicular lymphoma (FL), BCL-6/IgH in diffuse B-cell 
lymphoma (DLBCL), PAX-5 (Paired box 5) in small lymphocytic lymphoma, FAS (Fas cell 
surface death receptor) and RHOH (Ras homolog family member H) in non-Hodgkin's 
lymphomas (Jiang et al., 2002; Kramer et al., 1998; Torlakovic et al., 2002; Pasqualucci et al., 
2001). Furthermore, not only was AID shown to initiate somatic hypermutation in Chronic 
Lymphocytic Leukemia cells but highly expressed AID in patients with U-CLL more 
specifically was  also  found  to  be  directly  linked  to  increased  class  switching  and cell 
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proliferation levels (Palacios et al., 2010). 
 
 
 
1.5 AID targeting mechanisms 
 
 
When AID was first discovered, it was proposed to act on RNA, like its homologue 
APOBEC1(Muramatsu et al., 1999; Muramatsu et al., 2000; Muramatsu et al., 2007). However, 
subsequent evidence suggested that AID mutates single-stranded DNA (ssDNA). First, although 
purified AID, like all other AID/APOBEC enzymes can bind RNA as well as ssDNA, it strictly 
mutates (ssDNA) but has no apparent activity on RNA or double stranded DNA (dsDNA) 
oligonucleotides (Bransteitter et al., 2003; Sohail el al., 2003; Dickerson et al., 2003; Pham et 
al., 2003; Larijani et al., 2007; Yu et al., 2004; Larijani et al., 2007; Nabel et al., 2013). Second, 
AID is physically found at the switch region (S-region) of the Ig loci in B-cells undergoing CSR 
(Chaudhuri et al., 2007; Ranjit et al., 2011). Third, there is a strong association between AID 
and dU in DNA at loci undergoing SHM and CSR (Maul et al., 2011; Di Noia et al., 2002; 
Rada et al., 2002; Rada et al., 2004; Di Noia et al., 2007). Fourth, the WRC (W= A/T, R=A/G) 
sequence preference pattern of purified AID on ssDNA in vitro, or of AID-mediated mutations 
in the DNA genomes of bacteria, yeast or human cell lines made to express exogenous AID, 
are identical to that of SHM in vivo (Rada et al., 2004; Petersen-Mahrt et al., 2002; Larijani et 
al., 2007). 
On the other hand, there has also been a significant amount of evidence in support of   RNA 
13  
targeting by AID, namely that AID-dependent targeting of  Ig loci is  associated    with  certain 
nonconventional and non-catalytic aspects of uracil glycosylase activity (Begum et al., 2004; 
Yousif et al., 2014; Yousif et al., 2014; Begum et al., 2009), and that CSR requires de novo protein 
synthesis after AID expression (Begum et al., 2004). In addition, AID robustly binds RNA 
(Dickerson et al., 2003), can mutate viral RNA (Liang et al., 2013), and APOBEC-1, which is 
known to be an RNA-editing enzyme, also has the capacity to mutate DNA when expressed 
exogenously (Petersen-Mahrt et al., 2003). Based on these lines of evidence, it has been argued 
that SHM and CSR are not directly mediated by AID mutating Ig genes, but are rather by 
repair factors/polymerases and other DNA cleaving agents whose expression is modulated 
through RNA editing by AID (Begum et al., 2012). 
The DNA targeting model is also consistent with the finding that the absolute 
requirement for mutation of a gene by AID is active transcription, and that highly transcribed 
loci are preferred targets of mutation by AID (Peters et al., 1996; Storb et al., 1998; Storb et al., 
1998; Fukita et al 1998), since transcription generates and liberates ssDNA. For instance, at 
GC-rich sequences such as the Ig switch regions, the newly synthesized RNA transcript can 
associate with the DNA template strand creating a transient non-template strand R loop. 
Transcription also generates stem loops (SL), cruciforms and bubbles, due to relaxation of 
supercoiling in the wake of the traversing RNA polymerase (Dayn et al., 1992; Krasilnikov et 
al 1999). Indeed, such transient ssDNA structures, such as R-loops have been detected 
14  
abundantly at Ig switch sequences, where AID- induced mutations lead to double strand 
breaks (DSB) that initiate CSR (Yu et al., 2003; Yu et al., 2005; Stavnezer, 2011; Wright et 
al., 2004; Huang et al., 2007). We and others showed that these ssDNA substrates simulating 
these structures are efficiently mutated by AID in in vitro enzyme assays, or if made available 
through in vitro transcription of dsDNA (Yu et al., 2004; Larijani et al., 2007; Besmer et al., 
2006; Shem et al., 2009; Canugovi et al., 2009; Storb, 2014). 
It has also been suggested that AID interacts with various components of the 
transcriptional machinery including RNA polymerase II, Spt5, RNA polymerase II associated 
factor I (PAF1), spliceosome-associated factor CTNNBL1, RNA binding heterogeneous nuclear 
ribonucleoproteins (hnRNP) and splicing regulator polypyrimidine tract binding protein 2 
(PTBP2), and many of these interactions are dependent on the presence of RNA itself (Basu et 
al., 2011; Conticello et al., 2008; Pefanis and Basu, 2015; Pefanis et al., 2014; Hu et al., 2015; 
Mondal et al., 2016; Nowak et al., 2011; Pavri et al., 2010; Willmann et al., 2012; Taylor et al., 
2014; DiMenna and Chaudhuri, 2016; Zheng et al., 2015). Thus, both the process of transcription 
as well as interactions between AID and the transcription complex involve RNA (Fig. 5). 
 
 
1.6 Hypothesis 
 
Here, we examined the behavior of purified AID on DNA/RNA hybrid substrates 
designed to simulate structures found at immunoglobulin loci. We hypothesized that beyond 
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facilitating recruitment of AID, RNA may play a direct role in modulating its catalytic activity. 
To address this, we studied the activity of purified AID on DNA substrates bearing various 
sequences, including Ig region switch region sequences, in the presence or absence of hybridized 
RNA. We found that RNA can significantly boost the enzymatic activity of AID on ssDNA. We 
observed specificity, both in regards to DNA/RNA hybrid sequences able to elicit this effect, 
and surface residues of AID involved in this recognition. 
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(modified from Molecular Biology: Principles and Practice, 2012) 
 
 
 
Figure 5. RNA might play an important role in AID recruitment 
 
Earlier research suggests that the availability of ssDNA released during transcription attracts 
AID action since AID only mutates DNA. However, not only has AID been shown to bind RNA 
but defects in RNA processing during transcription contribute to altered AID activity. This 
suggests that while RNA itself is not a substrate for AID, it may play a role in AID targeting to 
the Ig locus. 
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Materials and Methods 
 
 
2.1 AID expression and purification 
 
Several types of highly purified AID were used in this study including bacterially expressed 
glutathione s-transferase (GST) tagged AID and eukaryotically expressed GST-AID or AID- His. 
We have previously described the expression and purification of GST-AID from bacteria 
(Dancyger et al., 2012; Abdouni et al., 2013; Larijani et al., 2007). Briefly, 50μl Escherichia coli 
BL21 (DE3) cells were transformed with 5μl of sequenced AID plasmid harboring the expression 
vector pGEX5.3 (GE Healthcare, USA) with GST-AID and incubated on ice for 20 min followed 
by heat shock for 45sec at 42°C. 200 μl of LB broth was supplemented before incubation at 37 °C 
and 225 rpm for 1 hr. 250 μl of the culture was plated on LB-ampicillin and incubated at 37 °C 
overnight. One colony of the glycerol stock of the transformed DE3 cells was picked to inoculate 
a 250 mL LB-ampicillin (100 ~g/mL) culture and then incubated at 37 °C and 225 rpm until the 
culture reached the log phase of growth and induced to express AID with 250 μl 1 mM IPTG at 
16 °C for 16 hrs. The culture was then pelleted using a Sorval Evolution RC Ultra Centrifuge at 
4°C, SOOO rpm for 10 min and the pellet was re-suspended in 20 mL of cold 1 X Phosphate 
buffered saline (PBS) and kept on ice. Cells were lysed twice using the French pressure cell press 
(Thermospectronic) and rinsed with cold 1 X PBS. The lysate was ultra-centrifuged at 8000 rpm 
and 4 °C for 10 min to remove cell waste and applied to Glutathione sepharose beads 
(Amersham) and AID protein was eluted as per the manufacturer's recommendations. Elution 
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fractions were collected at 4°C in 10 aliquots with 500 μl volumes each and kept on ice. Protein 
concentration and purity of each protein was tested using nanodrop spectrophotometry (Thermo 
Scientific) at 260 and 280 nm wavelengths. Protein fractions exceeding 1 mg/mL were dialysed 
using Snakeskin R Pleated Dialysis Tubing (Thermo Scientific) in Dialysis Buffer (1mM 
Dithiothreitol, 20mM Tris-HCl and 100 mM NaCl) twice at 4 °C. 50 μl of the purified protein 
was aliquoted in 1.5 mL micro centrifuge, flash frozen in liquid nitrogen for 30 sec and stored at -
80 °C.  
For eukaryotic expression of AID, an EcoRV/KpnI-flanked human AID fragment was cloned into 
pcDNA3.1-V5-6xHis- Topo which was modified with the addition of 2 extra His-residues to 
encode a 8x C-terminal His-tag. 50 x 10 cm plates, each seeded with 5 x105 HEK 293T cells were 
transfected with 5 g of plasmid per plate using Polyjet transfection reagent (Froggabio). Cells 
were incubated 48 hours at 37 °C, followed by resuspension in the lysis buffer 50 mM phosphate 
buffer pH 8.2 + 500 mM NaCl, 0.2 mM PMSF, 50 g/ml RNAse A and lysis using a French 
pressure cell press and   batch   binding   on   nickel   sepharose   beads (Amersham)   a per 
manufacturer's recommendations. Beads were serially washed with lysis buffer containing 
increasing concentrations (1 mM and 30 mM) of Imidazole, and eluted in lysis buffer containing 
500 mM of Imidazole. Alternatively, washed beads with bound AID-His were stored in AID 
storage buffer as a source of bead-bound AID. Eukaryotic GST-AID was likewise produced 
through the aforementioned transient transfection protocol with a pcDNA3.1-V5-6xHis-Topo 
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vector into which we cloned a previously described GST-AID encoding fragment (Larijani et al., 
2007). Cells were resuspended in PBS and lysed using a French Pressure cell, followed by 
binding to Glutathione Sepharose high performance beads (Amersham) as per manufacturer's 
recommendations. Beads were washed with PBS and resuspended in AID storage buffer.  
All purifications were subject to analysis by coomassie staining to test for protein concentration, 
purity, and expression levels using comparison to Bovine Serum Albumin (BSA) standards. 
Briefly, purified GST -AID proteins were run on 8%  sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) against BSA titrations followed by coomassie staining. Gels were 
stored by first drying onto chromatography paper (Whatman) using a slab dryer, at 80 °C for 2 
hrs. 
To verify the relative yield and purity of eukaryotic expression of AID, western blotting was 
used. Western blots were probed with anti-V5 (Abcam) at a 1:5000 dilution or anti-GST 
(SantaCruz) antibodies at a 1:500 dilution, followed by the secondary detection by Goat anti-
Rabbit IgG (SantaCruz) at a 1:5000 dilution. Site directed mutagenesis was used to generate 
GST-AID mutants. Briefly, the GST-fusion expression construct Pgex-5x-3 containing human 
AID gene (50ng/μl) was PCR-amplified using Phusion® High-Fidelity DNA Polymerase (2 
units/μl) (NEB) and forward and reverse primers (62.5ng/μl for each) that contained the indicated 
point mutations. Samples were incubated at 96°C for 1 min followed 35 cycles of 96°C for 30 
sec, 58°C for 30 sec and 72°C for 5 min and ending with 72°C for 10 min. To eliminate the 
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original template that was subsequently replicated, the hemi-methylated DNA was cleaved with 
the addition of DPN1 (20 units/ul) and incubating at 37°C for 4 hours followed by an overnight 
hold at 15°C. The PCR products were then dialyzed on millipore disks (0.025 um) in autoclaved 
water for 20 min, then reduced to 10ul in a heated speed vac machine. This was followed by 
transformation into XL blue E.coli bacteria, and sequence verification of correct clones. Two 
correct clones were then transformed into DE3 E.coli bacteria for protein production in the same 
manner described as wild type bacterially expressed GST-AID. For each form of AID (GST-AID, 
AID-His or GST-AID mutants), 2-6 independently purified preparations were used in this study. 
 
2.2 Preparation of substrates 
 
Partially single-stranded bubble substrates for AID enzyme assays were prepared as    described 
 
 
(Larijani et al., 2007; Larijani and Martin, 2007). Briefly, DNA and RNA oligonucleotides were 
synthesized and subject to FPLC purification (IDT). All oligonucleotides used are listed in Table 
2. 2.5 pmol of the target oligonucleotide was 5'-labeled with [γ-32P] dATP using polynucleotide 
kinase (New England Biolabs, USA). For simple bubble structures labelled, oligonucleotides 
were purified through mini-Quick spin DNA columns (Roche) and annealed with 3-fold excess cold 
strand (7.5 pmol) in a total volume of 50 μl by incubation starting at 96 °C and slow cooling at 1 
°C/min to 6 °C. Triplex bubble structures were prepared by mixing the labeled strand, the cold 
strand of the same length and shorter complimentary strand at a ratio of 1:3:9 and incubation at 
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96 °C and slow cooling at 1 °C/30 sec to 6 °C. Following annealing reactions and throughout the 
experimental phase, the expected formation and integrity of substrates were verified by 
electrophoresis on native (8-10%) polyacrylamide gels (6 % Glycerol, 8 % 
acrylamide:bisacrylamide 19:1) to confirm size and shape, as well as by MBN and RNase mapping 
of single-stranded regions. For MBN digestion, 50 fmol substrates were incubated with 0.1 or 1 
units of MBN in 10 μl containing MBN buffer (New England Biolabs) at 37 °C for 5 min 
followed by snap cooling and addition of 10 μl of 0.5 EDTA Na⁺  pH 8.0 and 2 μl of 0.1% SDS 
prior to electrophoresis on a 14% denaturing gel. For RNase digests, 2 μl of RNase A (1mg/ml) 
was incubated with 50 fmol substrate in 20 μl in the reaction buffer (50 mM Tris, pH 7.5; 50 mM 
NaCl) at 37 °C for one hour, prior to electrophoresis on an 8% native polyacrylamide gel. Gels 
were exposed to a Kodak Storage Phosphor Screen GP (Bio-Rad, Hercules, CA, USA) and 
visualized by PhosphorImager (Bio-Rad, Hercules, CA, USA) using Quantity One software (Bio-
Rad, Hercules, CA, USA). 
 
2.3 Alkaline cleavage deamination assay for AID activity 
 
We and others have previously described the alkaline cleavage assay for measuring the activity 
and catalytic rate kinetics of AID on various oligonucleotide-based substrates (Dancyger et al., 
2012; Abdouni et al., 2013; Larijani et al., 2007). Briefly, 5 nM radioisotope labelled substrates 
were incubated with 1-300 ng AID (depending on expression system for obtaining AID) in an 
Eppendorf Mastercycler Epigradient PCR thermal cycler (Fisher Scientific, Ontario, Canada) for 
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time periods ranging from 60 min to several hours in 100 mM phosphate buffer pH 7.21. Enzyme 
kinetics were performed using a range of substrate concentrations including 7.5, 5, 4, 2.5, 1.25, 
0.625, 0.315 and 0.15 nM. The 10 μl reaction volume was doubled by the addition of Uracil DNA 
glycosylase and buffer (NEB) for 30 min at 37 °C to excise the dU. 2 μl of 2 mM NaOH was added to 
the reaction followed by 8𝜇l of formamide-loading dye solution (95% formamide, 0.25% 
Bromophenol Blue) and incubated at 96 °C for 10 mins to cleave the abasic site. The gels were 
electrophoresed using 14% denaturing urea-formamide-acrylamide gel (1X TBE, 25% 
formamide, 14% acrylamide:bisacrylamide, 7M urea)  at 350V for 4.5-8 hours in TE buffer. This 
was followed by exposure to a Kodak Storage Phosphor Screen GP (Carestream Health Inc., 
Rochester, NY, USA) overnight and visualization by Phosphorimager Scanner (Bio-Rad).  The 
gels were quantified using Image Lab (Bio-Rad). 
2.4 Transcription-associated AID activity assay 
The plasmid construct used as substrate is pcDNA3.1 V5-6xHIS containing the human 
APOBEC3DE gene under T7 promoter control. Plasmid was isolated by maxiprep (Qiagen), 
followed  by  purification  of   the  supercoiled  fraction  through  Cesium  chloride       gradient 
centrifugation. The plasmid was transcribed in vitro using either the MEGAscript T7 
Transcription Kit (Ambion) or purified T7 RNA polymerase (New England Biolabs). For MEGA 
script T7 Transcription Kit, 0.25 pmol of supercoiled plasmid was transcribed in 1x transcription 
buffer, 2 μl of enzyme mix in 3.75 mM rNTPs. Reactions were incubated at 32 °C for 30 min. For 
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reactions using purified T7 RNA polymerase, 0.25 pmol of supercoiled plasmid was transcribed 
in the transcription buffer (40 mM Tris-HCl, 6 mM MgCl2, 2 mM spermidine, 1 mM 
dithiothreitol, pH 7.9) at 25 °C using 100 units of T7 polymerase in presence of 0.5 mM rNTPs 
(final volume of 20μl). Where added, 1.5 μg of human GST-AID, 10 unit of RNase H 
(Invitrogen,), and 2 μg of RNase A (sigma) were used in the transcription reactions. To detect 
AID-mediated mutations, 1μl of each reaction was amplified by deamination-specific nested PCR 
using Taq DNA polymerase and mutation-specific primers, as previously described (Larijani et 
al., 2005; Larijani et al; 2005). PCR products were analysed on an 1% agarose gel and band 
intensity was quantified using Image J 1.50i software. Data were submitted to independent 
samples T-test using IBM SPSS Statistics version 20 software. To confirm AID mediated 
mutations, we used PCR with AT-rich primers that bind to wild-type as well as AID mutated 
sequences with equal preference and thus do not select for mutated or unmutated plasmids. The 
1.2 kb-long PCR amplicons was subsequently TA-cloned, and 100-200 amplicons from each 
reaction were sequenced. AID-mutated mutations (C to T, or G to A on the sense and non-sense 
strands, respectively) were divided by total number of sequenced nucleotides to obtain the AID 
mediated mutation frequency. 
 
2.5 Electrophoretic mobility shift assay for AID binding 
 
Electromobility shift assay (EMSA) was used to measure the binding affinity of AID to substrates as 
previously described (Larijani et al., 2007; King et al., 2015). Briefly, a range of substrate 
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dilutions (7.5, 5, 4, 2.5, 1.25, 0.625, 0.315, 0.15, 0.075, 0.03 nM) were incubated with 1 μg of 
GST-AID in binding buffer (50 mM Tris-HCl pH 7.5; 2 μM MgCl; 50 mM NaCl; and 1 mM DTT) in 
a final volume of 10 μl incubated at 25 °C for 1 hour, followed by UV cross-linking on ice using 
the optimum setting of a UV-crosslinker (Stratagene) and rotated 180 degrees. EMSA loading 
dye (0.25 % Bromophenol Blue dye, 0.25 % Xylene Cyanol dye, 49.75 % Glycerol, and 49.75 % 
autoclaved MilliQ water) was added to each samples and reactions were electrophoresed at 4 °C 
on an 8% acrylamide native gel (6 % Glycerol, 8 % acrylamide:bisacrylamide 19:1), in 0.5X TBE 
buffer for 3 h, at 300 V and 4 °C. Gels were exposed to a Kodak Storage Phosphor Screen GP 
(Kodak Storage, BioRad) and visualized using a PhosphoImager Scanner (Molecular  Dynamics). 
Described. Kd values were derived from relative amounts of bound vs. free substrate at each 
substrate  concentration.  
 
2.6 AID activity and binding assay data quantification and statistical analysis 
 
Band densitometry was performed as previously described (Abdouni et al., 2013). Briefly, The 
Quantity One 1-D Analysis Software (Bio-Rad) was used to quantify band intensities of imaged 
gels. Typically, each experiment was repeated 4-10 times using 2-6 independently purified 
preparations of each type of purified AID. Quantification of each individual lane of an alkaline 
cleavage or EMSA gel was done 3 independent times to obtain an average value, representing a 
single-data point. Typically, triplicate measurements of each lane as well as duplicate r eact ion  
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lanes within each experiment exhibited a variation of <5%. Each graphed data point is thus the 
mean of all values obtained (12-30 values per data point) for a given AID:substrate combination. 
Data were graphed using GraphPad Prism software (GraphPad, San Diego, CA, USA). Error 
bars represent standard error. Paired T-test in GraphPad Prism was used to analyze data to 
scrutinize the significance of AID activity differences between each DNA/RNA hybrid and 
corresponding DNA/DNA substrate. 
 
2.7 AID structure and AID:nucleic acid complex formation modeling 
 
AID structure modeling and substrate docking was performed as described previously (King et 
al., 2015). Briefly, five APOBEC template structures were chosen as templates: mouse A2 NMR 
(PDB: 2RPZ), A3A NMR (PDB: 2M65), A3C X-ray (PDB: 3VOW), A3F-CTD X-ray   (PDB: 
4IOU) and A3G-CTD X-ray (PDB: 3E1U). All APOBEC templates were obtained from the 
PDB (http://www.rcsb.org) and visualized using PyMOL v1.7.6 (http://pymol.org). Using   the 
default parameters of   I-TASSER (http://zhanglab.ccmb.med.umich.edu/I-TASSER/)  (Roy et 
al., 2010; Zhang, 2008) full-length human AID (Hs-AID) were modeled from the APOBEC 
templates to generate 24 lowest-energy conformations. In each conformation, the entire structure 
was homology modeled except for the non-homologous 18 C terminal amino acids, which were 
modeled ab initio. ssDNA (5’-TTTTGCTT-3’) and RNA (5’-AUGCAGC-3’) were constructed 
in Marvin Sketch v.5.11.5 (http://www.chemaxon.com/products/marvin/marvinsketch/), while 
surface     topology     and     docking     parameters     were     generated     using  Swiss-Param 
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(http://swissparam.ch)  (Zoete  et  al.,  2011).  These output  files  served  as  docking ligands. 
Docking was performed using AutoDock Vina (http://vina.scripps.edu/). 9 catalytically 
accessible conformations of AID, as described previously (King et al., 2015) were docked with 
ssDNA and RNA, generating 9 low-energy clusters for each conformation, totaling 81 clusters. 
Residues within 3 Å of docked ssDNA or RNA were considered surface contact residues. 
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Results 
 
3.1 DNA/RNA hybrid bubble structures are stably formed and efficiently mutated by 
AID 
 
We and others have previously shown that purified AID can deaminate ssDNA but not 
RNA or dsDNA oligonucleotides in vitro (Sohail et al., 2003; Dickerson et al., 2003; Pham et 
al., 2003; Larijani et al., 2007; Yu et al., 2004; Larijani et al., 2007; Nabel et al., 2013). 
However, the activity of AID on DNA/RNA bubbles which simulate transient breathing of 
hybrid regions such as R loops, has not been examined. To investigate the role of RNA on AID 
activity, we designed oligonucleotide substrates in which a given 5'-labeled DNA 
oligonucleotide DNA sequence was used as ssDNA, or annealed to fully or partially 
complementary DNA or RNA strands to form dsDNA, a DNA/DNA bubble (TGCbub7-
DNA/DNA) or a DNA/RNA hybrid bubble (TGCbub7- DNA/RNA) (Fig. 6a). We chose these 
initial substrates, since we have previously shown that TGCbub7DNA/DNA is a favoured 
substrate of human AID in the alkaline cleavage assay, amongst a comprehensive panel of 
ssDNA shapes and sequences (Larijani et al., 2007). 
To confirm that DNA/RNA bubbles of the same sequence form similar structures as 
DNA/DNA bubbles we subjected substrates to native electrophoresis (Fig. 6b). We observed 
that DNA/DNA and DNA/RNA bubbles migrated slower than dsDNA. Since these fully dsDNA 
and DNA/DNA bubbles have near identical molecular weights, the slower migration of the 
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bubble vs. the fully ds DNA confirms the additional size footprint of the bubble region. In 
addition, DNA/RNA bubbles migrated slightly slower than their pure DNA counterparts of the 
same length and shape, as expected due to heavier weight of RNA (Table 2). To examine 
stability in the presence of AID, we incubated ssDNA, DNA/DNA and DNA/RNA bubbles with 
purified AID and observed that DNA/RNA bubble structures remained intact (Fig 6c). We 
further verified the expected structures of DNA/RNA bubbles by RNase and mung bean 
nuclease (MBN) digestions which degrade the RNA and only the ssDNA in the bubble regions, 
respectively (Fig 7). We conclude that DNA/RNA hybrid bubbles are formed in a similar manner 
to DNA/DNA bubbles, and are stable in the presence of AID. 
We then compared the activity of AID on DNA/DNA bubbles vs. DNA/RNA hybrids, 
with ssDNA and dsDNA substrates as controls. As expected, AID deaminated multiple dC 
located along the ssDNA target whereas activity was not detected on dsDNA (Fig. 8a). We found 
bacterially-expressed GST-AID can efficiently deaminate both DNA/DNA bubbles and 
DNA/RNA hybrids (Fig. 8b left panel, 53 vs. 22%). To ensure that activity on DNA/RNA 
hybrids is a bona fide property of highly purified AID, we tested AID purified in a different 
system using a different fusion tag. As shown in Fig 8b, we observed that no matter if AID was 
expressed in bacteria vs. eukaryotic cells, or purified using N terminal GST vs. C-terminal His 
tag, it mutated DNA/RNA bubbles efficiently (16 vs. 5.4%, 43 versus 35% and 8.2 versus 
10%). Based on these data we conclude that AID can efficiently mutate DNA/RNA bubbles. 
29  
 
 
 
 
 
 
 
Figure 6. DNA/RNA hybrid bubbles are stably formed. 
 
(a) Substrates designed to test AID activity on DNA/RNA hybrids include a 7 nt-long DNA/RNA 
bubble of random but pyrimidine-rich sequence and the equivalent DNA/DNA bubble, both 
containing the target dC (denoted by arrows) in the context of AID's favoured trinucleotide WRC 
motif TGC. All four substrates (ssDNA, bubbles and fully dsDNA) contain the same 5' labeled 
DNA target strand (denoted by *) annealed to either the equivalent sequence of partially 
complementary DNA or RNA, or a fully complementary DNA. (b) Native electrophoresis to 
compare migration of ssDNA, dsDNA, DNA/RNA bubbles and DNA/DNA bubbles (n=5) (c) 
Native electrophoresis of ssDNA, DNA/DNA and DNA/RNA bubbles to examine stability of 
DNA/RNA bubbles in the presence of AID. Substrates were incubated with purified AID followed 
by electrophoresis on native gels (n=5). 
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Figure 7. RNase and Mung Bean Nuclease mapping of DNA/DNA and DNA/RNA bubbles. 
 
(a) RNase digest of DNA/RNA and DNA/DNA bubbles to verify the formation of DNA/RNA 
bubbles, followed by native electrophoresis resulted in degradation of the RNA strand in 
DNA/RNA bubbles, whilst the DNA/DNA bubble was unaffected. (b) Mung Bean Nuclease 
(MBN) digestion of ssDNA target regions of DNA/RNA and DNA/DNA bubbles, followed by 
denaturing electrophoresis yielded a ~ 23 (+/- 2) nt product band indicative of digestion up to 
the edge of the double-stranded region within the DNA and DNA/RNA bubbles (n=8). 
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Figure 8.  DNA/RNA hybrid bubbles are efficiently mutated by AID. 
 
(a) Representative alkaline cleavage gel demonstrating that purified AID mutates ssDNA but not 
dsDNA. 50 fmol ssDNA or dsDNA were incubated with AID. (b) Purified AID can mutate 
DNA/RNA hybrid bubbles efficiently. To ensure that activity on DNA/RNA hybrids is a bona fide 
property of AID and not a function of a particular expression system or purification method, we 
tested highly purified AID that was expressed in either bacterial or eukaryotic cells and purified 
using either an N-terminal GST- or C-terminal His-tag. The four gels are representative alkaline 
cleavage experiments where 50 fmol TGCbub7-DNA/DNA or TGCbub7-DNA/RNA were 
incubated with bacterially expressed GST-AID (in solution), eukaryotically expressed GST-AID 
(bead-attached), eukaryotically expressed AID-His (in solution), and eukaryotically expressed 
AID-His (bead-attached) from left to right, respectively (n=3). Percent deamination for each 
reaction is shown below the lane. 
a  
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Table 2. Molecular weights and sizes of DNA and RNA substrates 
 
 
 
Substrate name Oligonucleotide Molecular Weight Total Molecular weight 
56 nt ssDNA DNA top strand (17458.3) 17458.3 
 
56 nt dsDNA 
DNA top strand (17458.3)  
34461.28 
DNA Complementary bottom strand 
(17002.98) 
TGCbub7-DNA/DNA 
DNA top strand (17458.3) 
34430.3 
DNA bottom strand (16972) 
TGCbub7-DNA/RNA 
DNA top strand (17458.3) 
35125.8 
RNA bottom strand (17667.5) 
56 nt ssDNA (GC-rich) DNA (GC-rich) top strand (17368.1) 17368.1 
TGCbub7-DNA/DNA 
(GC-rich) 
DNA (GC-rich) top strand (17368.1) 
34605.2 
DNA (GC-rich) bottom strand 
(17237.1) 
TGCbub7-DNA/RNA 
(GC-rich) 
DNA (GC-rich) top strand (17368.1) 
35501.2 
RNA (GC-rich) bottom strand 
(18133.1) 
56 nt ssDNA (SR) DNA (SR) top strand (16908.9) 
16908.9 
TGCbub7-DNA/DNA 
(SR) 
DNA (SR) top strand (16908.9) 34601.3 
DNA (SR) bottom strand (17692.4) 
TGCbub7-DNA/RNA 
(SR) 
DNA (SR) top strand (16908.9) 35371 
RNA (SR) bottom strand (18462.1) 
93 nt ssDNA DNA top strand (29331.9) 29331.9 
TGCbub45-DNA 
DNA top strand (29331.9) 
58075.5 
DNA bottom strand (28743.6) 
 
TGCbub45-DNA/DNA 
DNA top strand (29331.9) 
71606.4 
DNA bottom strand (28743.6) 
Short DNA bottom strand (13530.9) 
 
TGCbub45-DNA/RNA 
DNA top strand (29331.9) 
72256.2 
DNA bottom strand (28743.6) 
Short RNA bottom strand (14180.7) 
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3.2 DNA/RNA hybrids boost catalytic activity of AID in a sequence dependent manner 
 
We compared catalytic kinetics of bacterially-expressed GST-AID and eukaryotically- 
expressed AID-His on DNA/RNA and DNA/DNA bubbles. Both versions of highly purified 
AID exhibited a modest (1.3-fold) preference at the highest measured initial deamination 
velocity, for TGCbub7-DNA/DNA over the TGCbub7-DNA/RNA (Fig. 9). DNA/DNA and 
DNA/RNA bubble substrates are composed of a random sequence with a GC content of 63%, but 
a pyrimidine- rich target bubble region. To examine the impact of sequence, we designed 
substrates with a higher GC content (80%) and purine-rich bubble region. In sharp contrast to the 
aforementioned set, both GST-AID and AID-His exhibited substantial preference at highest 
measured initial velocity (13 and 4-fold) for the DNA/RNA hybrid TGCbub7- DNA/RNA (GC- 
rich) over its DNA/DNA counterpart TGCbub7-DNA/DNA (GC-rich) which supported lower 
AID activity than the non- GC-rich DNA/DNA substrate TGCbub7-DNA/DNA (Fig. 10a). We 
then designed DNA/RNA hybrids incorporating a bona fide switch region (SR) sequence from 
the human Sμ locus (Mills et al., 1990). Similar to substrates with a random GC-rich sequence, 
AID activity was diminished on the DNA/DNA bubble TGCbub7-DNA/DNA (SR), but at 
maximal velocity, GST-AID and AID- His both were significantly more active (3.5- and 4-fold, 
respectively) on the DNA/RNA hybrid TGCbub7-DNA/RNA (SR) (Fig. 10b). 
To ascertain whether these are reflective of recognition of DNA/RNA hybrids by AID, 
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we performed several additional experiments. First, we confirmed the same trend of AID 
preference on DNA/DNA vs. DNA/RNA bubbles on two additional versions of purified AID 
(Fig. 11). Second, to ensure that the preference of AID for DNA/RNA bubbles reflects 
recognition of the hybrid bubble itself rather than a boost in AID activity due to the presence of 
free RNA, we added excess free RNA to DNA/DNA bubbles but observed no change in AID 
activity (Fig. 12). We then designed longer substrates in which a third complementary strand of 
either DNA or RNA was used to form triplex structures (Fig. 13a). As with bubble substrates, 
we ensured proper formation of these by native electrophoresis (Fig. 13b). Both GST-AID and 
AID-His exhibited comparable catalytic kinetics on DNA/DNA/RNA and DNA/DNA/DNA 
triplex bubbles (Fig. 14). We conclude that RNA annealed to the target DNA strand can 
significantly boost AID activity in a sequence-dependent manner, but RNA that is free or 
annealed to complement of the target DNA strand does not have an appreciable effect. 
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Figure 9. DNA/RNA hybrids is active on AID across different substrate concentrations 
DNA/DNA and DNA/RNA bubbles with a random sequence but pyrimidine-rich DNA target 
regions were incubated with bacterially expressed GST-AID (left panel) or eukaryotically 
expressed AID-His (right panel). 1g GST-AID or 5 ng AID-His were incubated with substrate 
concentrations ranging 0.1 to 8 nM. A representative alkaline cleavage gel is shown as inset in 
the right panel. P values for TGCbub7-DNA/DNA vs. TGCbub7-DNA/RNA were 0.05 and not 
significant in the left and right panels respectively (n=6).
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Figure 10. DNA/RNA hybrids enhance AID activity in a sequence dependent manner. 
 
(a) Comparison of purified AID’s catalytic rate on DNA/DNA and DNA/RNA bubbles containing 
a GC-rich sequence with a purine-rich bubble region. P values were 0.004 and 0.01 for the left and 
right panels, respectively. (b) Comparison of purified AID’s catalytic rate on DNA/DNA and 
DNA/RNA bubbles containing human S region (SR) sequences from. P values were <0.001 and 
0.005 for the left and right panels, respectively. 
a 
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Figure 11. Two additional versions of purified AID also exhibit a similar pattern of relative 
catalytic kinetics on DNA/DNA and DNA/RNA bubbles. 
DNA/DNA and DNA/RNA bubbles of random or GC-rich makeup were incubated with 
eukaryotically expressed AID-His that was bead-attached (top row) or with bacterially expressed 
GST-AID that was bead-attached (bottom row). 1g equivalent of GST-AID beads or 5 ng 
equivalent of AID-His beads were incubated with substrate concentrations ranging 0.1 to 8 nM. 
P values were < 0.05 and 0.01, respectively, for TGCbub7-DNA/DNA vs. TGCbub7-
DNA/RNA, and for TGCbub7-DNA (GC-rich) vs. TGCbub7-DNA/RNA (GC-rich). 
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Figure 12. AID activity on DNA/RNA hybrids is not due to free RNA 
 
Equivalent amounts of excess free RNA, as used in the generation of DNA/RNA hybrid 
substrates, were added to reactions containing AID and DNA/DNA or DNA/RNA hybrids to 
examine the impact of non-annealed RNA on AID activity. 
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Figure 13. In Vitro R-loop model can be formed in a stable manner 
 
(a) Three substrates were used to measure the activity of purified AID on triplex bubble structures. 
 
A 93 nucleotide-long substrate containing a 45 nucleotide-long bubble region with the target dC 
(denoted by arrows) positioned in the WRC motif TGC is shown on top. Annealing of a 45 
nucleotide long DNA (middle) or RNA (bottom) results in the generation of triplex 
DNA/DNA/DNA or DNA/DNA/RNA structures, with either DNA or RNA annealed to the 
complementary strand of AID’s target strand. (b) Electrophoresis of substrates on native gels to 
confirm proper substrate formation as intended. 
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Figure 14. RNA-dependent enhancement of AID activity requires annealing to target 
DNA strand. 
Comparison of the catalytic kinetics of GST AID (left panel) or AID-His (right panel), 
on DNA/DNA/DNA, DNA/DNA/RNA, and DNA/DNA triplex bubble structures (Not 
Significant). 
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3.3 DNA/RNA hybrids enhance transcription-associated AID activity 
 
Since the generator of DNA/RNA hybrids is transcription, we sought to examine the role of 
DNA/RNA in modulating AID activity in the context of transcription. To this end, we employed a 
cell-free coupled transcription-deamination assay in which a purified supercoiled plasmid 
containing a T7 promoter is transcribed in vitro using T7 polymerase in the presence of AID (Fig. 
15, left panel). This assay has previously been employed in several studies to model the 
transcription dependence of AID activity in vitro (Shen et al., 2009; Canugovi et al., 2009). Said 
studies embedded an AID-favored WRC motif within the stop codon of an antibiotic-resistance 
gene on a plasmid, and measured transcription-dependent AID activity by evaluating the number 
of antibiotic-resistant bacterial colonies after transformation with substrate plasmid. We used a 
deamination-specific PCR assay which can be used to reliably compare relative amounts of 
plasmid DNA mutated by purified AID (Larijani et al., 2005; Larijani and Martin, 2012). As 
expected, in the presence of transcription and AID we detected highly mutated plasmid DNA by 
PCR (Fig. 15, right panel). With the addition of RNase H which catalyzes the cleavage of RNA 
in RNA/DNA substrates, we observed on average a 6-fold reduction in abundance of mutated 
plasmid DNA (Fig. 15 and 16a). This RNase H mediated reduction was consistent whether 
transcription was carried out using an in vitro transcription kit (Fig. 15, top right panel), or 
highly purified T7 RNA polymerase (Fig. 15, bottom right panel). To further verify these results, 
we amplified the target region of the substrate DNA using degenerate AT-rich 
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primers that anneal to AID-mutated and unmutated substrates without preference. We observed 
that indeed the reactions containing RNase H yielded reduced frequency of AID-mediated 
mutations (Fig. 16b). Although this assay lacks the complexities of eukaryotic transcription, the 
finding that degradation of DNA/RNA hybrids diminishes transcription dependent AID activity 
is consistent with the biochemical data performed earlier with the RNase A digestion. 
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Figure 15.  DNA/RNA hybrids enhance transcription-associated AID activity. 
 
Schematic of the cell-free transcription-associated AID activity assay: a plasmid substrate 
containing the T7 promoter upstream of a 1.5 kb target sequence is transcribed in vitro in the 
presence of AID, with or without the addition of RNase A or RNase H. Some plasmids are mutated 
by AID (depicted as red dots) at different levels, whilst others are unmutated. The reactions are 
then subject to one of two types of PCR. The first type employs deamination-specific primers and 
thus selectively amplifies AID-mutated DNA; representative gels of this PCR assay are shown in 
the right panel. The second type of PCR employs degenerate AT-rich primers devoid of any 
selectivity for AID mutated or unmutated DNA, thus providing an unbiased measure of AID 
activity in the reaction. 
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Figure 16. Presence of RNase H decreases AID-mediated mutations 
 
(a) Quantification of relative amounts of AID-mutated DNA as a result of transcription and in the 
presence or absence of RNase H. Results are reflective of band intensity quantitation of multiple 
independent experiments, using either purified T7 polymerase or a T7 polymerase-based in vitro 
transcription system. 11 agarose gels from independent deamination-specific PCR assays were 
quantified, representatives of which are shown in figure 15. P-value = 0.0005. (b) Sequencing of 
non-selective PCR-amplified DNA from transcription-associated AID activity assays, in the 
presence or absence of RNase H. For each reaction ~200 cloned amplicons, each ~ 1 kb in length, 
were sequenced. AID-mediated mutations (C to T or G to A) were divided by total nucleotide 
coverage to obtain AID-mediated mutation frequencies. Results are the average of 3 independent 
experiments, with a total coverage of 430,196 nucleotides sequenced. P value was < 0.0001. 
a  
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3.4 AID binds to DNA/RNA hybrids efficiently 
 
We sought to determine whether differential activity of AID on DNA/RNA vs. 
DNA/DNA bubbles is reflective of ability to bind AID. We previously showed that AID binds 
ssDNA with high affinity in the nM range, and that AID's preference for binding ssDNA is 
independent of sequence but dependent on the structure shape, with optimal targets being bubbles 
with 5-7 nt-long ssDNA regions. We found that AID bound TGCbub7-DNA/RNA as efficiently 
as ssDNA, and with ~ 25- fold lower affinity than TGCbub7-DNA/DNA (Fig. 17a, average Kd 
values of 8.6 vs. 0.3 nM). In contrast, when we examined AID binding to GC-rich bubbles, we 
found the DNA/RNA hybrid bound AID with a slightly higher affinity as compared to the 
DNA/DNA bubble (Fig. 17b, average Kd values of 0.40 vs. 0.61 nM), and with ~ 20-fold higher 
affinity than the DNA/RNA bubble of lower GC content (average Kd values of 0.40 vs. 8.6 nM). 
One possible explanation for the difference in AID's affinity to DNA/RNA hybrids depending 
on GC content could be that GC-rich hybrids form duplex structures with different structural 
conformations; however, we did not observe evidence of this through perturbed migration in 
native gels in conditions sensitive enough to detect the change in shape caused by protrusion of 
a 7 nt-long bubble (Fig. 6b, Table 2, Fig. 18). We conclude that AID is capable of binding 
DNA/RNA hybrids at least as efficiently as ssDNA of the same length, but depending on the 
sequence even more efficiently than DNA/DNA bubbles. Furthermore, differences between 
binding affinities of AID to DNA/RNA hybrids of varying GC content correlate with   relative 
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levels of AID activity on these substrates. 
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Figure 17. AID binds DNA/RNA hybrids efficiently. 
 
(a) EMSA was performed to compare binding affinity of purified GST-AID to ssDNA, 
DNA/DNA or DNA/RNA bubbles. (b) EMSA was performed to compare binding affinity of 
purified GST- AID to ssDNA (GC-rich), TGCbub7-DNA/DNA (GC-rich), or DNA/RNA (GC- 
rich) bubbles. Binding reactions contained 1g AID incubated with a substrate concentration 
range of 0.1 to 8 nM, followed by native electrophoresis to measure the relative proportions of 
free and AID-bound DNA substrate, from which Kd values were derived. 
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Figure 18. Native electrophoresis demonstrating proper formation of GC-rich and SR-set 
DNA/RNA hybrid bubbles. 
Native electrophoresis to compare relative migration of the DNA/RNA bubble relative to 
DNA/DNA bubble and ssDNA of the same length, for the GC rich (left panel) and SR sets (right 
panel) of DNA/DNA and DNA/RNA bubbles. 
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3.5 Surface residue mutations of AID impact relative preference for DNA/RNA hybrids 
 
Using a combination of in silico modeling supported by biochemical work we recently 
presented a possible functional structure for AID (King et al., 2015). We showed that due to its 
unusually highly positively charged surface, AID binds ssDNA sporadically across its surface 
with only a small proportion of AID:ssDNA binding events positioning the target ssDNA in one 
of two ssDNA binding grooves that pass over the catalytic pocket (Fig. 19a,b). We found that this 
sporadic binding of ssDNA on the surface, in addition to closure of AID’s catalytic pocket, are 
responsible for AID’s unusually low catalytic efficiency. To gain insight into binding of 
DNA/RNA hybrids, we simulated AID:RNA complexes in the same manner. We found that in 
contrast to ssDNA binding, RNA binding was more focused on a specific portion of AID’s 
surface: 56% (45/81) of AID:RNA complexes bound RNA in a groove distal from the catalytic 
pocket (Fig. 19c), whilst 17% (14/81) bound in one of the ssDNA binding grooves and 23% 
(19/81) bound elsewhere on the surface. This putative RNA binding groove is composed of 
residues contributed by 3, 4, 5, 3, 4, 5, loops 7 and 9 (Table 3). We noted that the distance 
between the putative RNA binding groove and ssDNA-binding groove 2 is such that DNA/RNA 
hybrid bubbles are predictedto bind the surface of AID using these two grooves (Fig. 20). 
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Figure 19. Simulated AID complexes with DNA, RNA or DNA/RNA hybrids. 
 
Docking of ssDNA on the surface of AID illustrating the primary ssDNA binding groove (a), the 
secondary ssDNA binding groove (b), and a putative RNA binding groove (c). Top panels are 
representative conformations of ssDNA or RNA bound to the respective groove. Bottom panels 
show residues lining each groove in blue (for ssDNA binding) or red (for RNA binding) without 
the bound ssDNA or RNA. Purple residues represent the three Zn-coordinating residues (H56, C87 
and 90) and catalytic glutamic acid (E58), constituting the catalytic pocket. Key residues that 
determine relative efficacy of AID binding to DNA/RNA vs. DNA/DNA bubbles are labeled. 
51  
 
 
 
 
 
 
 
 
Figure 20. Prediction of DNA/RNA hybrids binding to the surface of AID 
 
A probable conformation of a DNA/RNA hybrid bubble bound on the surface of AID. RNA in 
red is located in the RNA binding groove whilst the DNA strand in blue is bound along the 
secondary DNA binding groove due to the relative proximity of the two grooves. 
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Table 3. RNA contact frequencies of residues lining the putative RNA binding groove. 
 
 
Residue RNA binding frequency (%) 
Q135 89 
G133 82 
H130 82 
R107 76 
S105 69 
R77 67 
R131 64 
L104 62 
L98 60 
R177 60 
T79 60 
A132 58 
F109 58 
K142 58 
P102 58 
D143 56 
I136 56 
Y146 56 
V134 53 
A137 51 
L106 51 
T140 49 
V32 49 
R99 44 
I138 40 
L198 40 
S173 40 
L180 38 
F81 36 
Y184 36 
G197 33 
L176 29 
P182 29 
K34 27 
L181 27 
N101 27 
T195 27 
D187 22 
E185 22 
R36 22 
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We reasoned that the ssDNA binding grooves and putative RNA binding groove are 
likely to play a role in the recognition of DNA/RNA hybrids. To examine this notion, we tested 
a library of 41 AID mutants including mutants of the most probable ssDNA contact regions and 
Hyper IgM mutants of surface residues. Of these 41 mutants, 28 were residues from the DNA 
binding grooves, 11 were from the RNA binding groove, and 11 were Hyper IgM mutants (Mu et 
al., 2012; Durandy et al; 2006; Ouandani et al., 2016). We measured the relative activities of 
each mutant on the 6 different bubble substrates used in our study (DNA/DNA and DNA/RNA 
bubbles with random, GC-rich and SR sequence). Based on relative levels of activity on 
DNA/DNA vs. DNA/RNA bubbles, the 41 mutants tested fell broadly into 4 categories (Fig. 
21). The most prominent, category I, contained 17/41 mutants that behaved generally like wild 
type (wt) AID in that they were active on both DNA/DNA and DNA/RNA bubbles but more 
active on the former. Category II contained 8/41 mutants which were quite weakly active (< 2% 
deamination or < 5% of wt) on both DNA/DNA and DNA/RNA bubbles. Category III contained 
5/41 mutants that were active on both DNA/DNA and DNA/RNA bubbles, but exhibited 
significantly more activity on the latter, the opposite preference to that of wt AID. Category IV 
was the second largest and contained 11/41 mutants, which had weak to undetectable activity on 
DNA/DNA but retained activity on DNA/RNA hybrids. 
Within the DNA binding grooves, we found 12 mutants (R25H, R25N, E26R, G54A, 
R63A, D89A, D89R, D96R, E117A, R119A, R171Y, R178D) in category I, 5 mutants (R50D, 
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A91K, R112C, K52D and R24D-R63D) in category II, 4 mutants (F11I, R24A, R50A and R63D) 
in category III, and 7 mutants (F15L, R24D, R24W, R25A, R25D, R25del and E26A) incategory 
IV. Within the RNA binding groove, we found 4 mutants (R107A, F109A, Q135A and R190X) 
in category I, 2 mutants (L106P and D143A) in category II and 5 mutants (L98R, H130P, 
G133V, I136K and M139T) in category IV. 3/11 Hyper IgM mutants (L106P, R112C and 
G125E) were nearly inactive (category II). Interestingly, 7/8 enzymatically active Hyper IgM 
mutants (F15L, R24W, L98R, H130P, G133V, I136K and M139T) fell into category IV. The only 
Hyper IgM mutant that did not ablate activity on DNA/DNA bubbles was R190X. We confirmed 
the specific preference of category IV mutants for DNA/RNA over DNA/DNA bubbles by 
carrying out catalytic kinetics (Fig. 22). We also tested each mutant on the GC-rich and SR-set 
of DNA/DNA and DNA/RNA bubbles, and observed similar results (Fig. 23, 24 and 25). 
Interestingly, the sole Hyper IgM mutant (R190X) which fell into category I on the DNA/DNA 
and DNA/RNA substrates of random sequence, also fell into category 4 when tested on the GC- 
rich and SR-set. Taken together, since the putative RNA binding groove and the two ssDNA- 
binding grooves house most residues whose mutations perturbed AID activity on DNA/DNA 
relative to DNA/RNA hybrids, we conclude that specific residues on AID’s surface mediate 
RNA recognition thus playing a role in targeting DNA/RNA hybrids. 
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Figure 21. Surface residue and Hyper IgM mutants of AID differentially impact activity 
on DNA/DNA and DNA/RNA bubbles. 
A panel of 41 AID mutants were tested for activity on TGCbub7-DNA/DNA and TGCbub7- 
DNA/RNA to determine relative preference. Mutants included mutations of surface residues 
located proximal to, or within one of AID’s two putative ssDNA binding grooves or putative RNA 
binding groove, as well as known Hyper IgM mutants of surface residues (indicated by the *). 
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Figure 22. Enzymatic kinetics of surface residue and Hyper IgM mutants of AID on 
DNA/RNA hybrids 
Catalytic rates of selected category IV mutants on TGCbub7-DNA/DNA and TGCbub7- 
DNA/RNA, to confirm the significantly enhanced preference for the latter. A range of 0.1-8nM 
substrate concentration were incubated with 1g GST-AID. P values for all shown graphs  were 
<0.05. For each mutant, two independently purified preparations were tested. 
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Figure 23. Surface residue and Hyper IgM mutants of AID exhibit differential preference 
for GC-rich and SR DNA/DNA vs. DNA/RNA bubbles. 
Top shows a panel of 36 AID mutants tested for activity on TGCbub7-DNA/DNA (GC-rich) vs. 
TGCbub7-DNA/RNA (GC-rich) to determine relative preference. Bottom panel shows a 
comparison of the activity of the set of AID mutants on TGCbub7-DNA/DNA (SR) vs. TGCbub7- 
DNA/RNA (SR). 
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Figure 24. Enzymatic kinetics of Surface residue and Hyper IgM mutants of AID on GC- 
rich DNA/RNA hybrids 
Catalytic rates of selected category IV mutants on TGCbub7-DNA/DNA (GC-rich) and TGCbub7- 
DNA/RNA (GC-rich), to confirm the significantly enhanced preference for the latter. A range of 
0.1-8nM substrate concentration were incubated with 1g GST-AID. P values for all shown graphs 
were <0.05. For each mutant, two independently purified preparations were tested. 
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Figure 25. Enzymatic kinetics of Surface residue and Hyper IgM mutants of AID on SR 
 
DNA/RNA hybrids 
 
Catalytic rates of selected category IV mutants on TGCbub7-DNA/DNA (SR) and TGCbub7- 
DNA/RNA (SR), to confirm the significantly enhanced preference for the latter. A range of 0.1- 
8nM substrate concentration were incubated with 1g GST-AID. P values for all shown graphs 
were <0.05. For each mutant, two independently purified preparations were tested. 
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Summary 
 
AID mutates antibody genes to initiate antibody diversification by preferentially 
targeting single stranded DNA structures in vitro and in vivo such as stem-loops, bubbles and 
R-loop regions that are released during the process of transcription. 
In this study, we sought to investigate the role of RNA itself in attracting AID activity. 
We designed stable substrates that simulate transient breathing of DNA/RNA hybrids during 
transcription and we confirmed the structural integrity of these substrates through several 
assays and digests. We then measured the activity of purified AID on DNA/RNA hybrids and 
discovered that not only does AID bind to DNA/RNA hybrids but if the DNA/RNA hybrids 
contain a higher GC content, as in the case in immunoglobulin switch region sequences, AID 
favours these over pure DNA sequences. We confirmed these results using AID purified in a 
variety of different manners, to ensure our results reflect a bona fide property of AID itself. 
Moreover, we used a cell-free coupled transcription-AID activity assay to measure 
transcription dependent AID activity in vitro in the presence of RNaseH and found that RNA 
also stimulates transcription-dependent AID activity. 
We then studied how AID can interact with DNA/RNA hybrids by performing in silico 
docking of RNA and AID. We discovered a putative RNA binding groove on the surface of 
AID which can accommodate the RNA strand of DNA/RNA hybrids, whilst allowing the DNA 
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strand to be situated in one of two DNA binding grooves that we previously identified. To 
validate the insights gained through the in silico structural and docking work, we used 41 
mutants of AID targeting surface residues predicted to interact with ssDNA or RNA. We found 
that DNA/RNA hybrids restored activity of several AID mutants including those found in 
Hyper IgM patients that otherwise lack activity on pure DNA substrates. Given the prevalence 
of DNA/RNA hybrids at Immunoglobulin switch sequences, our findings provide evidence of 
a novel role for RNA in regulating AID activity. 
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Discussion 
 
The link between AID activity and transcription is well established. AID’s targeting of 
highly transcribed genes together with its specificity for ssDNA in vitro have led to the model 
that transcription liberates ssDNA substrates for AID to act on. The long-standing puzzle within 
this model has been why AID preferentially targets Ig loci whilst seemingly sparing other highly 
transcribed genes. Three facets of the transcription process appear to play a role in this regulation: 
firstly, it was recently shown that AID targets Ig and non-Ig loci at sites that are marked by a 
unique convergence of promotors, enhancers and bidirectional transcription, and it has long been 
appreciated that Ig loci are home to numerous robust and bidirectional promoters and enhancers 
(Buerstedde et al., 2014; Meng et al., 2014; Qian et al., 2014; Alinikula and Schatz, 2014). 
Secondly, several factors associated with the transcriptional machinery, including the RNA 
exosome and spliceosome, have been implicated in recruiting AID to sites of transcription 
(Basu et al., 2011; Conticello et al., 2008; Pefanis et al., 2014; Hu et al., 2015; Mondal et al., 
2016; Nowak et al., 2011; Pavri et al., 2010; Willmann et al., 2012; Taylor et al., 2014; 
DiMenna and Chaudhuri, 2016; Zheng et al., 2015). Thirdly, intronic RNA has been suggested 
to directly bind AID and contribute to its targeting to switch regions (DiMenna and Chaudhuri, 
2016; Zheng et al., 2015). Thus, RNA has been implicated in recruitment of AID both through 
direct interaction, and indirectly through association with transcription and RNA-
processingfactors. 
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Our data suggest an additional role for RNA in that in the absence of any other proteins, 
RNA itself boosts the catalytic activity of AID on switch region-like sequences. Like dsDNA, 
DNA/RNA hybrids in vivo are of course fully complementary in sequence. It has previously 
been shown that AID can efficiently target supercoiled fully complementary dsDNA, 
presumably due to natural strand breathing liberating transient ssDNA regions in the form of 
bubbles and stemloops (Storb, 2014; Shen, 2007). In the same manner that DNA/DNA bubble 
oligonucleotide substrates simulate this transient breathing, the DNA/RNA hybrid structures 
studied here were intended to simulate transiently single stranded bubble or stemloop 
DNA/RNA hybrids formed due to natural breathing of multi kb-long GC-rich R loop 
dsDNA/RNA known to be abundantly present at Ig loci (Yu et al., 2003; Yu el al., 2005; 
Stavnezer, 2011; Wright et al., 2004; Huang et al., 2007). 
There are several possible mechanisms to explain this RNA-mediated enhancement of 
AID's catalytic activity. We found that AID can bind DNA/RNA hybrids with high nM range 
affinities, and depending on the sequence, even more efficiently than DNA/DNA substrates. 
Structural modeling of AID in complex with ssDNA or RNA hybrids hinted at a putative RNA 
binding groove present on the surface of AID, distal to the catalytic pocket, in addition to the 
two ssDNA-binding groove previously identified. Recent work suggests that sporadic ssDNA 
binding on the surface of AID is a bottleneck for activity, since only a low proportion of ssDNA 
bound in one of said ssDNA binding grooves pass over the catalytic pocket and thus can 
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potentially position a dC for mutation (King et al., 2015). Simulations suggested that when 
binding DNA/RNA hybrids AID likely binds the RNA strand in said RNA binding groove and 
the DNA strand in ssDNA- binding groove 2 since it is proximal to the RNA binding groove (Fig. 
20) relative to the separation between ssDNA-binding grooves 1 and 2. In contrast, when binding 
DNA/DNA, the target ssDNA strand has an equal probability of binding in either ssDNA- 
binding grooves 1 or 2 (Fig. 19a,b). Because ssDNA binding groove 2 forms fewer deamination- 
conducive complexes than groove 1 (King et al., 2015), this may partly explain reduced activity 
on DNA/RNA substrates. Indeed, mutations that perturb ssDNA binding groove 1 (F11I, F15L, 
R24D, R24W, R25A, R25D, R25del, E26A and R50A) hinder/ablate AID activity on DNA/DNA 
bubbles. Interestingly, these mutations retain, or even enhance activity on DNA/RNA substrates. 
Partial rescue of these mutants by DNA/RNA hybrids may indicate that DNA/RNA hybrids 
guide the target ssDNA preferentially to ssDNA binding groove 2 and limit binding to the 
disrupted DNA binding groove 1. Non-disruptive DNA binding groove 1 mutants (e.g. R25H 
and R25N) which reflect variations naturally present in orthologous AID and other APOBECs, 
did not disrupt activity on DNA/DNA activity and thus exhibited comparable activity to wild 
type AID. Likewise, disruption of residues specific to ssDNA binding groove 2 (R63A, R63D 
and D96R) did not ablate activity on DNA/DNA substrates, presumably because the dominant 
ssDNA binding groove 1 was left intact and was capable of positioning ssDNA for deamination. 
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Since GC-rich and SR DNA/RNA hybrid and DNA/DNA bubbles contain highly GC- 
rich bubble regions which are likely less flexible due to inter-strand hydrogen bonding, it is 
possible that the two ssDNA strands of the bubble are less able to bind in both ssDNA binding 
grooves 1 and 2, as compared to bubbles of lower GC content, thus accounting for generally 
lower activity of AID on GC-rich and SR DNA/DNA bubbles as compared to DNA/DNA 
bubbles of a random sequence. In contrast, in GC-rich or SR DNA/RNA hybrids, RNA fit in the 
RNA binding groove may guide the target DNA strand to ssDNA-binding groove 2 because of 
the closer proximity of these two grooves as described above, thus increasing the likelihood of 
the target ssDNA passing over the catalytic pocket. In support of this, mutation of residues 
specific to DNA binding groove 2, but not groove 1, hinder or ablate activity on GC-rich or SR 
DNA/RNA substrates. R190X in which the C-terminal α7 domain is truncated is of interest as 
we and others have shown that the highly flexible α7 domain likely adopts several conformations 
on the surface of AID but favors binding to a region distal from the catalytic pocket (King et al., 
2015; Methot et al., 2015). We noted that this region also encompasses many of the residues in 
the putative RNA binding groove and thus α7 has a high likelihood of at least partially blocking 
RNA binding. In R190X, the absence of α7 likely increases the availability of the RNA binding 
groove thus resulting in significant activity on GC-rich DNA/RNA substrates. Notably, when 
examining point mutants localized to the RNA binding region, none ablated activity on 
DNA/RNA bubbles. This suggests that the RNA binding groove contains highly redundant RNA- 
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contact residues; a notion that is also supported by AID:RNA complex simulation data (Table 
3). This is in contrast to point mutations of ssDNA binding grooves which more frequently impact 
AID activity, and may be taken as evidence for the biological importance of RNA binding to the 
surface of AID. 
In addition to the role played by specific surface residues of AID located along the ssDNA 
and RNA binding grooves, it is possible that non-B form duplex structures are assumed by 
DNA/RNA hybrids of a certain GC content, which may enhance binding to the surface of AID. 
Indeed, GC-rich DNA/RNA hybrids have been shown to frequently adopt an intermediate 
conformation between an A-form of a dsRNA structure and a B-form DNA duplex (Shaw et al., 
2008). Whatever the case may be, human and mouse SR sequences targeted by AID during CSR 
are particularly GC-rich. It appears that this is an evolutionary adaptation given that SRs of 
earlier- diverged species such as amphibians are less GC-rich (Roy and Lieber, 2009; Zarrin et 
al., 2004; Roy et al., 2008). It remains to be determined if DNA/RNAhybrids directly boost AID 
activity in vivo, as we have observed for purified AID in vitro. If so, the inherent catalytic 
preference for GC- rich and SR DNA/RNA hybrids could be viewed as an example of 
enzyme:substrate co-evolution. 
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Future directions 
 
While this study proposes an important role for RNA in recruiting AID, future 
experiments will be conducted to further explore this hypothesis. This includes expanding the 
list of mutants that were tested on the DNA/RNA hybrids. Currently 41 mutants were used, 28 
of which are residues from the DNA binding grooves, 11 are from the RNA binding groove, and 
11 are Hyper IgM mutants. The following experiments should include all the Hyper IgM mutants 
identified in literature as well as designing multiple surface residue mutations further targeting 
the putative RNA binding region on the surface of AID, or mutants targeting combinations of 
the RNA as well as ssDNA binding grooves. Since single point mutants in the RNA binding 
groove didn’t ablate AID activity due to the redundancy of the RNA-contact residues, a more 
comprehensive library can be composed by adding double and triple surface residue mutants that 
targets the RNA and DNA binding grooves separately or together. 
In addition, further work with the transcription-dependent AID activity assay using DNA 
sequences of various GC contents, or actual gene sequences from the Ig loci will be conducted 
to probe for differential role of RNA, according to sequence context. In the future, novel assays 
can be designed using yeast or mammalian cell lines to study the role of DNA/RNA hybrids in 
recruitment of AID in vivo. 
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